Cardinal Health ( (CAH) ) has released its Q1 earnings. Here is a breakdown of the information Cardinal Health presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Cardinal Health, Inc., headquartered in Ohio, is a global healthcare services and products company that provides pharmaceuticals and medical products to various healthcare facilities, enhancing supply chain efficiency and integrated care coordination. In its latest quarterly earnings report, Cardinal Health announced a 22% increase in revenue, reaching $64 billion, driven by growth in branded and specialty pharmaceutical sales. The company’s GAAP operating earnings rose by 18% to $668 million, while non-GAAP operating earnings increased by 37% to $857 million, primarily due to acquisitions and increased contributions from pharmaceutical products. The Pharmaceutical and Specialty Solutions segment saw a 23% revenue increase, while the Global Medical Products and Distribution segment grew by 2%. Cardinal Health’s management remains optimistic about future growth, with expectations of continued demand for its products and services, despite potential challenges from regulatory changes and market conditions.